Skip to main contentBack to Top

The Center's research efforts focus on two main areas:

First, discovery and validation of biomarkers for disease prediction and diagnosis, secondly, pharmacomics and drug discovery for personalized medicine.

Established in the summer of 2002, the Center for Biotechnology and Genomic Medicine (CBGM) at the Medical College of Georgia (MCG) at Augusta University (AU) was developed to promote interdisciplinary and translational research in Biotechnology and Genomic Medicine with the ultimate goal of promoting predictive, preventive, personalized and participatory (4P) medicine.

The Center's research efforts focus on two main areas: 1) discovery and validation of biomarkers for disease prediction and diagnosis, 2) pharmacomics and drug discovery for personalized medicine.  CBGM is home of four internationally renowned programs in diabetes research: The Environmental Determinants of Diabetes in the Young (TEDDY), the Prospective Assessment in Newborns of Diabetes Autoimmunity (PANDA), the Diabetic Complications Consortium (DiaComp) and the Mouse Metabolic Phenotype Consortium (MMPC). Additional research programs include autoimmune diseases, transplantation, and cancer. These research programs are supported by an annual extramural funding of approximately $12 million.

The center houses several state-of-the-art high throughput and high content facilities for genetics, genomics, proteomics, drug screening and bioinformatics. The center continues to recruit independent investigators with expertise in diverse disciplines such as genomics, proteomics, immunology, medicinal chemistry, drug development, biostatistics and computational biology. This multidisciplinary approach provides an avenue for investigators to interact and stimulate novel ideas.


screenshot of Paul's Diabetes app



Most risk calculators for diabetic microvascular complications are limited to research labs because of how complicated the statistical analysis is. This calculator was developed to fill the gap and allow individuals to estimate their own specific risk.

Please click on the image of the calculator to be taken to the website.

THE INFORMATION PROVIDED BY THIS TOOL IS NOT MEDICAL ADVICE AND CANNOT BE USED TO DIAGNOSE OR TREAT ANY MEDICAL CONDITION. We do not retain any information that you provide in connection with your use of the tool.


gifts icon  GIVE A GIFT!


CBGM logo


Contact Us

Center for Biotechnology & Genomic Medicine

Health Sciences Campus

Interdisciplinary Research Center

Sarah Gross
Office Specialist : 706-721-3410
Debbie Ellison
Dept. Admin. : 706-721-3433

1462 Laney Walker Blvd. Augusta, GA 30912

8 a.m. - 5 p.m.





Man in blue shirt and glasses stands with elbow propped on computer

Richard McIndoe, PhD, will direct coordinating unit for new, national research initiative in diabetes, obesity

The National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes, or MPMOD, is a multicenter initiative being established by the National Institute of Diabetes and Digestive and Kidney Diseases.

Man and woman in white coat stand in lab in front of computer screen

Antibodies to common antibiotic possible new risk factor for type 1 diabetes

It’s not uncommon for antibiotics to prompt production of antibodies because the body views them as foreign.

Woman (left) and man in lab

Noninvasive technique collects sufficient tear fluid to look for biomarkers of health and disease

One day a tear fluid workup could be as routine as bloodwork during a physical exam as well as in diagnosing a myriad of conditions, from dry eye disease to Alzheimer’s.

Two men in white coats stand in hallway

New algorithm dramatically increases the speed of identifying two cancer drugs that work synergistically

The algorithm could significantly speed up the process of identifying which drugs work together.

More News for CBGM